心脑舒通治疗脑动脉硬化症和脑血栓形成后遗症50例

Xinnao Shutbng therapy in 50 patients with cerebral arteriosclerosis and the sequelae of cerebral thrombosis

本文以心脑舒通治疗脑动脉硬化症和脑血栓形成后遗症共50例(男32例,女18例;年龄61±7yr),剂量为30-45mg,tid,8wk为一个疗程。并与长春西汀治疗组30例作对照,两者疗效相仿。心脑舒通对自觉症状总有效率为83％;精神症状总有效率为90％;神经症状总有效率为83％;心脑舒通对血液流变学各项指标均有显著改善作用,并能选择性增加脑缺血部位的血供。

The reported 50 patients (M 32, F 18; age 61±SD.7 yr) with cerebral arteriosclerosis and the sequelae of cerebral thrombosis were received Xinnao Shutong (Tribulas terretris L, consisting of furostanol and spirostanol) 30-45 mg tid 8 wk as a course. Another 30 patients with the same suffering were treated with vinpocetine 5 mg, tid, as control, and 4 wk as a course. Both efficacies were similar. The former subjective symptoms were improved by 83%; psychic symptoms 90% and neurologic symptom 83%. The hemorheologic change were also improved after the treatment. It protected cerebral tissues from ischemia and had selected increase in blood supply of .brain.